N1-benzyl-4-fluoro-N3-phenylisophthalamide

ID: ALA5286808

Max Phase: Preclinical

Molecular Formula: C21H17FN2O2

Molecular Weight: 348.38

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(NCc1ccccc1)c1ccc(F)c(C(=O)Nc2ccccc2)c1

Standard InChI:  InChI=1S/C21H17FN2O2/c22-19-12-11-16(20(25)23-14-15-7-3-1-4-8-15)13-18(19)21(26)24-17-9-5-2-6-10-17/h1-13H,14H2,(H,23,25)(H,24,26)

Standard InChI Key:  BWDXKXJTDKUEGJ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 26 28  0  0  0  0  0  0  0  0999 V2000
   -1.7851    1.0333    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7851    0.2083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0707   -0.2041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0707   -1.0326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7851   -1.4450    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3542   -1.4407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3558   -1.0289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3558   -0.2037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0702    0.2087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7846   -0.2037    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4991    0.2087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2135   -0.2037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2135   -1.0322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9299   -1.4403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6401   -1.0285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6401   -0.2032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9281    0.2086    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0702    1.0337    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3561    0.2081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4995   -0.2041    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2140    0.2083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9239   -0.2032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6401    0.2046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6401    1.0329    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9257    1.4450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2140    1.0333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 12  2  0
  9 18  2  0
  8 19  1  0
 19  3  2  0
 20  2  1  0
 21 20  1  0
 22 21  1  0
 23 22  2  0
 24 23  1  0
 25 24  2  0
 21 26  2  0
 26 25  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5286808

    ---

Associated Targets(Human)

PPARG Tclin Peroxisome proliferator-activated receptor gamma (15191 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 348.38Molecular Weight (Monoisotopic): 348.1274AlogP: 4.01#Rotatable Bonds: 5
Polar Surface Area: 58.20Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.76CX Basic pKa: CX LogP: 4.01CX LogD: 4.01
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.73Np Likeness Score: -1.67

References

1. Orsi DL, Ferrara SJ, Siegel S, Friberg A, Bouché L, Pook E, Lienau P, Bluck JP, Lemke CT, Akcay G, Stellfeld T, Meyer H, Pütter V, Holton SJ, Korr D, Jerchel-Furau I, Pantelidou C, Strathdee CA, Meyerson M, Eis K, Goldstein JT..  (2023)  Discovery and characterization of orally bioavailable 4-chloro-6-fluoroisophthalamides as covalent PPARG inverse-agonists.,  78  [PMID:36542958] [10.1016/j.bmc.2022.117130]

Source